Immunophenotyping in multiple myeloma and related plasma cell disorders

被引:89
|
作者
Kumar, Shaji [1 ]
Kimlinger, Teresa
Morice, William
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
关键词
monoclonal gammopathy; myeloma; plasma cell; immunophenotyping; MULTIPARAMETER FLOW-CYTOMETRY; MINIMAL RESIDUAL DISEASE; LOW CD27 EXPRESSION; HIGH-DOSE THERAPY; BONE-MARROW; PERIPHERAL-BLOOD; MONOCLONAL GAMMOPATHY; LABELING INDEXES; UNDETERMINED SIGNIFICANCE; C-KIT;
D O I
10.1016/j.beha.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell disorders form a spectrum ranging from the asymptomatic presence of small monoclonal populations of plasma cells to conditions like plasma cell leukemia and multiple myeloma, in which the bone marrow can be replaced by the accumulation of neoplastic plasma cells. Immunophenotyping has become an invaluable tool in the management of hematological malignancies and is increasingly finding a role in the diagnosis and monitoring of plasma cell disorders. Multiparameter flow cytometry has evolved considerably during the past decade with an increasing ability to screen large numbers of events and to detect multiple antigens at the same time. This, along with a better understanding of the phenotypic heterogeneity of the clonal plasma cells in different disorders, has made immunophenotyping an indispensible tool in the diagnosis, prognostic classification and management of plasma cell disorders. This book chapter addresses the approaches taken to evaluate monoclonal plasma cell disorders, and the different markers and techniques that are important for the study of these diseases. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:433 / 451
页数:19
相关论文
共 50 条
  • [1] Utility of Flow Cytometry Immunophenotyping in Multiple Myeloma and Other Clonal Plasma Cell-Related Disorders
    Paiva, Bruno
    Almeida, Julia
    Perez-Andres, Martin
    Mateo, Gema
    Lopez, Antonio
    Rasillo, Ana
    Vidriales, Maria-Belen
    Lopez-Berges, Maria-Consuelo
    Miguel, Jesus F. San
    Orfao, Alberto
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2010, 78B (04) : 239 - 252
  • [2] Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders
    Coppola, Antonio
    Tufano, Antonella
    Di Capua, Mirko
    Franchini, Massimo
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2011, 37 (08): : 928 - 944
  • [3] Plasma Cell Immunophenotyping Improve Prognostic Stratification of Multiple Myeloma Patients
    Meddour, Yanis
    Rahali, Momahed Cherif
    Belakehal, Salah Eddine
    Benfenatki, Nacera
    Ardjoune, Fatma Zohra
    Chaib, Samia
    Djidjik, Reda
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2018, 11 (01)
  • [4] Utility of immunophenotyping of plasma cells in multiple myeloma
    Gertz, Morie A.
    Buadi, Francis K.
    LEUKEMIA & LYMPHOMA, 2016, 57 (02) : 252 - 253
  • [5] Multiple myeloma and other plasma cell disorders
    Gómez, ED
    Sanz, DM
    REVISTA CLINICA ESPANOLA, 1999, 199 : 52 - 57
  • [6] The comprehensive clinical management of multiple myeloma and related-plasma cell disorders
    Richardson, Paul G.
    Blade, Joan
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (01) : 1 - 3
  • [7] The Detection Of The Immunophenotyping Of Plasma Cells In Patients With Multiple Myeloma
    Ouyang, Jian
    Li, Ermin
    Zhou, Min
    Chen, Junhao
    Xia, Yangquan
    Xu, Xuejing
    Wang, Xian
    Zhou, Rong-Fu
    BLOOD, 2013, 122 (21)
  • [8] Integrative medicine in multiple myeloma and plasma cell disorders
    Okolo, Onyemaechi
    Wertheim, Betsy C.
    Larsen, Ashley
    Sweeney, Nathan W.
    Ahlstrom, Jennifer M.
    Gowin, Krisstina
    COMPLEMENTARY THERAPIES IN MEDICINE, 2023, 73
  • [9] Multiple Myeloma and Related Disorders
    不详
    CANCER FORUM, 2006, 34 (01) : 80 - 80
  • [10] PLASMA-CELL ACID-PHOSPHATASE SCORE IN MULTIPLE-MYELOMA AND RELATED DISORDERS
    HOFFMANN, JJML
    BREED, WPM
    SWAAKLAMMERS, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 59 (01) : 67 - 72